{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:08:43Z","timestamp":1773799723246,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003010","name":"Ege \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jgar.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T11:41:27Z","timestamp":1581680487000},"page":"147-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model"],"prefix":"10.1016","volume":"22","author":[{"given":"Sinan","family":"Mermer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuncer","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Bolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohret","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tansu","family":"Yamazhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husnu","family":"Pullukcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilgin","family":"Arda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Sipahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Ulusoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguz Resat","family":"Sipahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.02.001_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14787210.2014.890049","article-title":"An updated approach to healthcare-associated meningitis","volume":"12","author":"Bardak-Ozcem","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2020.02.001_bib0010","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u2014tenth edition. CLSI document M07-A10","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.jgar.2020.02.001_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijantimicag.2005.08.011","article-title":"Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis","volume":"26","author":"Sipahi","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.02.001_bib0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2005.06.010","article-title":"Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model","volume":"26","author":"Suntur","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.02.001_bib0025","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01996-12","article-title":"Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model","volume":"57","author":"Bardak-Ozcem","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jac\/dkl007","article-title":"Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis","volume":"57","author":"Gerber","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MD.0b013e3181d5453d","article-title":"Staphylococcus aureus meningitis: case series and literature review","volume":"89","author":"Aguilar","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl. 3","key":"10.1016\/j.jgar.2020.02.001_bib0040","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID Study Group for Infections of the Brain (ESGIB). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.02.001_bib0045","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.02.001_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MD.0b013e318243442b","article-title":"Methicillin-resistant Staphylococcus aureus meningitis in adults: a multicenter study of 86 cases","volume":"91","author":"Pintado","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jgar.2020.02.001_bib0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/sur.2012.091","article-title":"Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis","volume":"14","author":"Sipahi","year":"2013","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.jgar.2020.02.001_bib0060","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.idc.2009.06.007","article-title":"Newer \u03b2-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime","volume":"23","author":"Bazan","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jgar.2020.02.001_bib0065","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dks006","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy","volume":"67","author":"Ho","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0070","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jac\/dku392","article-title":"Successful use of ceftaroline for the treatment of MRSA meningitis secondary to an infectious complication of lumbar spine surgery","volume":"70","author":"Balouch","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2146\/ajhp130246","article-title":"Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy","volume":"71","author":"Bucheit","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jgar.2020.02.001_bib0080","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40265-017-0785-2","article-title":"Early use of ceftaroline fosamil in the United States veterans health care system","volume":"77","author":"Britt","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jgar.2020.02.001_bib0085","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1128\/AAC.00285-13","article-title":"Efficacy of ceftaroline fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model","volume":"57","author":"Stucki","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0090","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/AAC.00286-13","article-title":"Efficacy of ceftaroline fosamil against penicillin-sensitive and -resistant Streptococcus pneumoniae in an experimental rabbit meningitis model","volume":"57","author":"Cottagnoud","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0095","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkr019","article-title":"Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus","volume":"66","author":"Jacqueline","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jac\/dky489","article-title":"Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain","volume":"74","author":"Chauzy","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.02.001_bib0105","series-title":"Antibiotics in laboratory medicine","first-page":"295","article-title":"Measurements of antibiotics in human body fluids: techniques and significance","author":"Chapin-Robertson","year":"1991"},{"key":"10.1016\/j.jgar.2020.02.001_bib0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/jcm.20.3.311-316.1984","article-title":"Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay and fluorescence immunoassay","volume":"20","author":"Pfaller","year":"1984","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:54:33Z","timestamp":1761990873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520300278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"alternative-id":["S2213716520300278"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.02.001","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}